A Step in Flux to Suppress Axion Isocurvature
Priyesh Chakraborty, Junyi Cheng, Matthew Reece, and Zekai Wang

TL;DR
This paper proposes a novel mechanism using a topological BF-type mass term to suppress axion isocurvature perturbations during inflation, potentially relaxing constraints on the inflationary Hubble scale.
Contribution
It introduces a flux quantization-based mass mechanism for axions, enabling large masses during inflation and zero mass at the QCD transition, with detailed cosmological embedding scenarios.
Findings
The mechanism suppresses axion isocurvature perturbations effectively.
It can be realized through a phase transition involving brane nucleation.
Possible UV completions include extra-dimensional gauge theories and string theory.
Abstract
The QCD axion in the pre-inflation scenario faces a stringent isocurvature constraint, which requires a relatively low Hubble scale during inflation. If the axion was heavier than the Hubble scale during inflation, its isocurvature is suppressed and the constraint disappears. We point out a novel mechanism for achieving this, relying on the topological nature of a BF-type (monodromy) mass for the axion. Such a mass term has an integer coefficient, so it could naturally have been very large during inflation and exactly zero by the time of the QCD phase transition. This integer can be viewed as a quantized flux, which is discharged in a first-order phase transition that proceeds by the nucleation of charged branes. This mechanism can be embedded in cosmology in several different ways, with tunneling during, at the end of, or after inflation. We provide a detailed case study of the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSpaceflight effects on biology · Laser Applications in Dentistry and Medicine · Photoreceptor and optogenetics research
